Prolonged cholinergic enrichment influences regional cortical activation in early Alzheimer’s disease

References

• AwhEJonidesJSmithEEDissociation of storage and rehearsal in verbal working memoryPsychol Sci199672531
   Web of Science ®Google Scholar
• BaldoJVSchwartzSWilkinsDRole of frontal versus temporal cortex in verbal fluency as revealed by voxel-based lesion symptom mappingJ Int Neuropsychol Soc20061289690017064451
   PubMed Web of Science ®Google Scholar
• BirksJGrimley EvansJIakovidouVVRivastigmine for Alzheimer’s disease (Cochrane Review)Cochrane Database Syst Rev2000a4CD00119111034705
   PubMedGoogle Scholar
• BirksJSMelzerDBeppuHDonepezil for mild and moderate Alzheimer’s disease (Cochrane Review)Cochrane Database Syst Rev2000b4CD00119011034704
   PubMedGoogle Scholar
• BraverTSCohenJDNystromLEA parametric study of prefrontal cortex involvement in human working memoryNeuroimage1997549629038284
   PubMed Web of Science ®Google Scholar
• BrunAEnglundBGustafsonLClinical and Neuropathological criteria for frontotemporal dementiaJ Neurol Neurosurg Psychiatry199457416188163988
   PubMed Web of Science ®Google Scholar
• CorbettaMShulmanGLMiezinFMSuperior parietal cortex activation during spatial attention shifts and visual feature conjunctionScience199527080257481770
   PubMed Web of Science ®Google Scholar
• CourtneySMPetitLHaxbyJVThe role of prefrontal cortex in working memory: examining the contents of consciousnessPhilos Trans R Soc Lond B Biol Sci19983531819289854254
   PubMed Web of Science ®Google Scholar
• DaviesRRGrahamKSXuerebJHThe human perirhinal cortex and semantic memoryEur J Neurosci2004202441615525284
   PubMed Web of Science ®Google Scholar
• FawBPre-frontal executive committee for perception, working memory, attention, long-term memory, motor control, and thinking: a tutorial reviewConscious Cogn2003128313912617864
   PubMed Web of Science ®Google Scholar
• FolsteinMFFolsteinSEMcHughPRMini-Mental-State: A practical method for grading the cognitive state of patients for the clinicianJ Psychiatry Res19751218998
   PubMed Web of Science ®Google Scholar
• GoekoopRRomboutsSAJonkerCChallenging the cholinergic system in mild cognitive impairment: a pharmacological fMRI studyNeuroimage2004231450915589109
   PubMed Web of Science ®Google Scholar
• GoekoopRScheltensPBarkhofFCholinergic challenge in Alzheimer patients and mild cognitive impairment differentially affects hippocampal activation – a pharmacological fMRI studyBrain20061291415716251213
   PubMed Web of Science ®Google Scholar
• GronGBrandenburgIWunderlichAPInhibition of hippocampal function in mild cognitive impairment: targeting the cholinergic hypothesisNeurobiol Aging200627788716298243
   PubMed Web of Science ®Google Scholar
• HachinskiVCIliffLDZilhkaECerebral blood flow in dementiaArch Neurol19753263271164215
   PubMed Web of Science ®Google Scholar
• HowardDPattersonKThe Pyramids and Palm Trees Test1992Suffolk, VAThames Valley Test Co
   Google Scholar
• KadirAAlmkvistOWallAPET imaging of cortical 11C-nicotine binding correlates with the cognitive function of attention in Alzheimer’s diseasePsychopharmacology (Berl)20061885092016832659
   PubMed Web of Science ®Google Scholar
• KadirADarreh-ShoriTAlmkvistOChanges in brain (11)C-nicotine binding sites in patients with mild Alzheimer’s disease following rivastigmine treatment as assessed by PETPsychopharmacology (Berl)200719110051417310387
   PubMed Web of Science ®Google Scholar
• KircherTTErbMGroddWCortical activation during cholinesterase-inhibitor treatment in Alzheimer disease: preliminary findings from a pharmaco-fMRI studyAm J Geriatr Psychiatry20051310061316286445
   PubMed Web of Science ®Google Scholar
• LojkowskaWRyglewiczDJedrzejczakTThe effect of cholinesterase inhibitors on the regional blood flow in patients with Alzheimer’s disease and vascular dementiaJ Neurol Sci20032161192614607313
   PubMed Web of Science ®Google Scholar
• McKeithIGGalaskoDKosakaKConsensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshopNeurology1996471113248909416
   PubMed Web of Science ®Google Scholar
• McKhannGDrachmanDFolsteinMClinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s DiseaseNeurology198434939446610841
   PubMed Web of Science ®Google Scholar
• NobiliFKoulibalyMVitaliPBrain perfusion follow-up in Alzheimer’s patients during treatment with acetylcholinesterase inhibitorsJ Nucl Med2002439839012163621
   PubMed Web of Science ®Google Scholar
• NobiliFVitaliPCanforaMEffects of long-term Donepezil therapy on rCBF of Alzheimer’s patientsClin Neurophysiol20021131241812140003
   PubMed Web of Science ®Google Scholar
• PetersenRCSmithGEWaringSCAging, memory, and mild cognitive impairmentInt Psychogeriatr19979Suppl 16599447429
   PubMedGoogle Scholar
• PosnerMIRaichleMEImages of Mind1997New YorkScientific American Library
   Google Scholar
• PotkinSGAnandRFlemingKBrain metabolic and clinical effects of rivastigmine in Alzheimer’s diseaseInt J Neuropsychopharmacol200142233011602028
   PubMed Web of Science ®Google Scholar
• PriceCJMummeryCJMooreCJDelineating necessary and sufficient neural systems with functional imaging studies of neuropsychological patientsJ Cogn Neurosci1999113718210471846
   PubMed Web of Science ®Google Scholar
• RicciPTZelkowiczBJNebesRDFunctional neuroanatomy of semantic memory: recognition of semantic associationsNeuroimage1999988969918730
   PubMed Web of Science ®Google Scholar
• RomanGCTatemichiTKErkinjunttiTVascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International WorkshopNeurology199343250608094895
   PubMed Web of Science ®Google Scholar
• RomboutsSABarkhofFVan MeelCSAlterations in brain activation during cholinergic enhancement with rivastigmine in Alzheimer’s diseaseJ Neurol Neurosurg Psychiatry2002736657112438467
   PubMed Web of Science ®Google Scholar
• SabsevitzDSMedlerDASeidenbergMModulation of the semantic system by word imageabilityNeuroimage20052718820015893940
   PubMed Web of Science ®Google Scholar
• SaykinAJWishartHARabinLACholinergic enhancement of frontal lobe activity in mild cognitive impairmentBrain200412715748315140813
   PubMed Web of Science ®Google Scholar
• ShanksMFMcGeownWJForbes-McKayKERegional brain activity after prolonged cholinergic enhancement in early Alzheimer’s diseaseMagn Reson Imaging2007258485917442521
   PubMed Web of Science ®Google Scholar
• ShimizuSHanyuHIwamotoTSPECT follow-up study of cerebral blood flow changes during Donepezil therapy in patients with Alzheimer’s diseaseJ Neuroimaging200616162316483272
   PubMed Web of Science ®Google Scholar
• StefanovaEWallAAlmkvistOLongitudinal PET evaluation of cerebral glucose metabolism in rivastigmine treated patients with mild Alzheimer’s diseaseJ Neural Transm20061132051816049637
   PubMed Web of Science ®Google Scholar
• VandenbergheRPriceCWiseRFunctional anatomy of a common semantic system for words and picturesNature199638325468805700
   PubMed Web of Science ®Google Scholar
• VandenbulckeMPeetersRDupontPWord reading and posterior temporal dysfunction in amnestic mild cognitive impairmentCereb Cortex2007175425116603712
   PubMed Web of Science ®Google Scholar
• VeltmanDJRomboutsSADolanRJMaintenance versus manipulation in verbal working memory revisited: an fMRI studyNeuroimage2003182475612595179
   PubMed Web of Science ®Google Scholar
• VenneriAImaging treatment effects in Alzheimer’s diseaseMagn Reson Imaging2007259536817446028
   PubMed Web of Science ®Google Scholar
• VenneriAShanksMFPicturing dementia: experience with SPECT20027th International Geneva/Springfield Symmposium on Advances in Alzheimer TherapyGeneva, CH
   Google Scholar
• VenneriAShanksMFStaffRTCerebral blood flow and cognitive responses to rivastigmine treatment in Alzheimer’s diseaseNeuroreport20021383711924899
   PubMed Web of Science ®Google Scholar
• WilcockGKLilienfeldSGaensEEfficacy and safety of galantamine in patients with mild to moderate Alzheimer’s disease: multicentre randomised controlled trial. Galantamine International-1 Study GroupBMJ20003211445911110737
   PubMed Web of Science ®Google Scholar